CRISPR-Cas13d Induces Efficient mRNA Knockdown in Animal Embryos
- PMID: 32768421
- DOI: 10.1016/j.devcel.2020.07.013
CRISPR-Cas13d Induces Efficient mRNA Knockdown in Animal Embryos
Abstract
Early embryonic development is driven exclusively by maternal gene products deposited into the oocyte. Although critical in establishing early developmental programs, maternal gene functions have remained elusive due to a paucity of techniques for their systematic disruption and assessment. CRISPR-Cas13 systems have recently been employed to degrade RNA in yeast, plants, and mammalian cell lines. However, no systematic study of the potential of Cas13 has been carried out in an animal system. Here, we show that CRISPR-RfxCas13d (CasRx) is an effective and precise system to deplete specific mRNA transcripts in zebrafish embryos. We demonstrate that zygotically expressed and maternally provided transcripts are efficiently targeted, resulting in a 76% average decrease in transcript levels and recapitulation of well-known embryonic phenotypes. Moreover, we show that this system can be used in medaka, killifish, and mouse embryos. Altogether, our results demonstrate that CRISPR-RfxCas13d is an efficient knockdown platform to interrogate gene function in animal embryos.
Keywords: CRISPR-Cas13; Cas13d; MZT; RNA targeting; early development; embryogenesis; killifish; knockdown; medaka; zebrafish.
Copyright © 2020 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of Interests The authors declare no competing interests.
Comment in
-
A CRISPR cut for messenger RNAs.Lab Anim (NY). 2020 Nov;49(11):317-319. doi: 10.1038/s41684-020-00661-3. Lab Anim (NY). 2020. PMID: 33020605 No abstract available.
Similar articles
-
Efficient Inhibition of HIV Using CRISPR/Cas13d Nuclease System.Viruses. 2021 Sep 16;13(9):1850. doi: 10.3390/v13091850. Viruses. 2021. PMID: 34578431 Free PMC article.
-
CRISPR/Cas13d-mediated efficient KDM5B mRNA knockdown in porcine somatic cells and parthenogenetic embryos.Reproduction. 2021 Jul 8;162(2):149-160. doi: 10.1530/REP-21-0053. Reproduction. 2021. PMID: 34096883 Free PMC article.
-
Cytosolic CRISPR RNAs for efficient application of RNA-targeting CRISPR-Cas systems.EMBO Rep. 2025 Apr;26(7):1891-1912. doi: 10.1038/s44319-025-00399-4. Epub 2025 Feb 26. EMBO Rep. 2025. PMID: 40011676 Free PMC article.
-
CRISPR-Cas13 Precision Transcriptome Engineering in Cancer.Cancer Res. 2018 Aug 1;78(15):4107-4113. doi: 10.1158/0008-5472.CAN-18-0785. Epub 2018 Jul 18. Cancer Res. 2018. PMID: 30021724 Review.
-
Advances in CRISPR-Cas systems for RNA targeting, tracking and editing.Biotechnol Adv. 2019 Sep-Oct;37(5):708-729. doi: 10.1016/j.biotechadv.2019.03.016. Epub 2019 Mar 27. Biotechnol Adv. 2019. PMID: 30926472 Review.
Cited by
-
Programmable RNA Targeting Using CasRx in Flies.CRISPR J. 2020 Jun;3(3):164-176. doi: 10.1089/crispr.2020.0018. CRISPR J. 2020. PMID: 32584145 Free PMC article.
-
CRISPR technologies for genome, epigenome and transcriptome editing.Nat Rev Mol Cell Biol. 2024 Jun;25(6):464-487. doi: 10.1038/s41580-023-00697-6. Epub 2024 Feb 2. Nat Rev Mol Cell Biol. 2024. PMID: 38308006 Review.
-
Preventing autosomal-dominant hearing loss in Bth mice with CRISPR/CasRx-based RNA editing.Signal Transduct Target Ther. 2022 Mar 14;7(1):79. doi: 10.1038/s41392-022-00893-4. Signal Transduct Target Ther. 2022. PMID: 35283480 Free PMC article.
-
Enhancing Animal Disease Resistance, Production Efficiency, and Welfare through Precise Genome Editing.Int J Mol Sci. 2022 Jun 30;23(13):7331. doi: 10.3390/ijms23137331. Int J Mol Sci. 2022. PMID: 35806334 Free PMC article. Review.
-
Efficient Inhibition of HIV Using CRISPR/Cas13d Nuclease System.Viruses. 2021 Sep 16;13(9):1850. doi: 10.3390/v13091850. Viruses. 2021. PMID: 34578431 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials